Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

J
j. Ilic V.L. - EFFEKT OF PARAPROTEINS ON PLATELET AGGREGATION
J.M. Soucie . - INCIDENCE OF LEUKEMIA IN PATIENTS WITH HEMOPHILIA
Jackson S.P. - IDENTIFICATION OF A NOVEL MECHANISM PROMOTING STATIONARY ADHESION OF DISCOID PLATELETS SHEAR DEPENDENT CONVERSION OF PLATELET TETHERS TO PSEUDOPODIA
  - THE NON-CATALYTIC SIGNALLING FUNCTION OF PI 3-KINASE P110GAMMA PROMOTES PLATELET ACTIVATION AND THROMBUS FORMATION
  - HIGH RESOLUTION IMAGING OF PLATELETS IN VITRO AND IN VIVO
Jackson S. - ENDOTHELIAL CELL TYPE AND ACTIVATION STATE AFFECTS SOLUBLE P-SELECTIN MEDIATED LEUKOCYTE ADHESION
Jackson S.P. - SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY
Jackson D.E. - IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE
Jackson S.P. - HYPERGLYCAEMIA AND DYSLIPIDAEMIA ARE NOT SUFFICIENT TO INDUCE PLATELET HYPERACTIVITY IN THE DIABETIC APOLIPOPROTEIN E-/- MOUSE
  - ROLE OF PI-3 KINASE BETA ISOFORM ON ADP-INDUCED PLATELET RESPONSES
  - MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS
Jackson C.L. - TISSUE TRANSGLUTAMINASE DOES NOT STABILIZE ARTERIAL PLAQUES IN THE APOE DEFICIENT MOUSE
Jackson S.P. - SELECTIVE SIGNALLING ROLE FOR PI 3-KINASE P110BETA IN THROMBIN-INDUCED CLOT RETRACTION
Jackson S. - FERRIC CHLORIDE INDUCES VASCULAR INJURY AND THROMBOSIS BY OXIDATIVE INJURY TO RED BLOOD CELLS
Jacob J. - IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
Jacobs N. - P2X1 RECEPTORS AS NEW REGULATORS OF NEUTROPHIL LIFE SPAN
Jacobs J. - TETRASPANIN CD9 MODULATES VASCULAR SMOOTH MUSCLE CELL MIGRATION AND PROLIFERATION IN VITRO AND NEOINTIMA FORMATION IN VIVO
Jacobs N. - ANTIPHOSPHOLIPID ANTIBODIES DISTURB 2D LATTICE FORMATION OF ANNEXINE A5 ON ACTIVATED PLATELETS
Jacobsen N. - COMBINED EFFECTS OF RFVIIA AND RFXIII ON CLOT FORMATION AND STABILITY IN PLASMA AND BLOOD FROM NORMAL DONORS AND FROM THROMBOCYTOPENIC PATIENTS
Jacobson B. - MONOCYTE PLATELET COMPLEXES: A POTENTIAL FLOW CYTOMETRIC ASSAY FOR SCREENING PRE-THROMBOTIC EVENTS IN HIV POSITIVE PATIENTS
Jacobson R. - IMPROVING COMMUNICATION AND SUPPORTING EFFICIENT PRODUCT USE WITH ELECTRONIC RECORDING
Jacobson B.F. - DELAYED HYPERSENSITIY TO LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN PREGNANCY
  - A STUDY OF THE UTILITY OF THROMBOELASTOGRAPHY IN THE MONITORING OF ASPIRIN THERAPY
Jacobson A.K. - UNFRACTIONATED HEPARIN (UFH) OR LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AS PERIOPERATIVE BRIDGING THERAPY IN PATIENTS WITH MECHANICAL HEART VALVES (MHVS) ON LONG-TERM ORAL ANTICOAGULANTS (OAC): RESULTS FROM THE REGIMEN REGISTRY
Jacquemin M.G. - A LIMITED NUMBER OF ANTI-IDIOTYPIC ANTIBODIES NEUTRALIZE FVIII INHIBITORS AND RESTORE FULL FVIII ACTIVITY IN THE PLASMA OF HAEMOPHILIA PATIENTS
  - ACTIVATION OF HUMAN LUNG ENDOTHELIAL CELLS INDUCES THE RELEASE OF A FVIII STORAGE POOL
Jacquemin E. - ASSESSMENT OF THE PREDICTIVE VALUE OF PFA-100 TM OCCLUSION TIME CONCERNING THE HAEMORRHAGIC RISK OF TRANSPARIETAL NEEDLE LIVER BIOPSY IN CHILDREN
Jacquemin M. - INHIBITOR ANTIBODY LE2E9 AGAINST FACTOR VIII C1 DOMAIN INHIBITS PHOSPHOLIPID BINDING AND ALTERS FACTOR XASE ENZYME COMPLEX FORMATION
Jacubovics N. - A NOVEL GPIB ALPHA BINDING PROTEIN ON STREPTOCOCCUS GORDONII INDUCES PLATELET ROLLING AT LOW SHEAR
  - USING A PROTEOMIC APPROACH TO IDENTIFY SPECIFIC STREPTOCOCCAL PROTEINS RESPONSIBLE FOR INDUCING PLATELET AGGREGATION IN INFECTIVE ENDOCARDITIS
Jaeger U. - A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS
Jaeken J. - HYPERREACTIVE PLATELETS IN PATIENTS WITH GS DEFICIENCY
Jafari H. - FACTOR XI DEFICIENCY IN SOUTHERN IRAN AND REVIEW OF LITERATURE
Jaffer A.K. - NOVEL RISK FACTORS FOR DEEP VEIN THROMBOSIS IN HOSPITALIZED PATIENTS
Jaffey J. - ECONOMIC EVALUATION OF POINT-OF-CARE MONITORING DEVICES FOR LONG-TERM ORAL ANTICOAGULATION THERAPY
  - DO POINT OF CARE DEVICES IMPROVE OUTCOMES IN PATIENTS ON ORAL ANTICOAGULANT THERAPY
Jagadeeswaran P. - ZEBRAFISH: FROM HEMATOLOGY TO HYDROLOGY
Jager R. - SUCCESSFUL IMMUNE TOLERANCE INDUCTION (ITI) OF HIGH-RESPONDING INHIBITORS WITH A HIGH PURITY FVIII/VWF CONCENTRATE
Jahan R. - A NEW ANIMAL MODEL OF CATHETER-SELECTIVE MIDDLE CEREBRAL ARTERY THROMBO-OCCLUSIVE STROKE: DEMONSTRATION OF RAPID REPERFUSION BY LOCAL PLASMIN INFUSION
Jahangir A. - SINGLE MOLECULE FORCE SPECTROSCOPY OF FIBRINOGEN
  - DE NOVO ATOMIC FORCE MICROSCOPY OF INTRACORONARY THROMBUS: NEW INSIGHTS INTO FIBRIN CLOT ARCHITECTURE AND IMPLICATIONS FOR FIBRINOLYSIS
Jain N. - INHIBITOR DEVELOPMENT IN SEVERE HEMOPHILIA A: IS THE RISK ASSOCIATED WITH PRODUCT TYPE?
Jairajpuri M.A. - THE ANTITHROMBIN III SERINE-380 P14 HYDROXYL MAKES CRITICAL CONTRIBUTIONS TO METASTABILITY OF THE NATIVE CONFORMATION AND TO STABILIZATION OF THE HEPARIN-BOUND ACTIVATED STATE
  - REMOVAL OF THE POSITIVE CHARGE BUT NOT THE HYDROPHOBIC STEM FROM LYSINE-222 IN ANTITHROMBIN III BETA-SHEET-A REDUCES FACTOR XA INHIBITION RATES AND INCREASES HEPARIN BINDING AFFINITY
Jais C. - ABCIXIMAB-DEPENDENT THROMBOCYTOPENIA IN PATIENTS WITH ACUTE CORONARY SYNDROMES CAN OCCUR BY DIFFERENT MECHANISMS
Jaïs X. - TREATMENT OF VTE DURING PREGANCY WITH A ONCE-DAILY REGIMEN OF LMWH
Jakeli N. - THE USE OF LOW-MOLECULAR HEPARIN IN PRAGNANTS
Jakiela B. - THE ADDITIVE ANTIPLATELET ACTION OF CLOPIDOGREL IN PATIENTS WITH CORONARY ARTERY DISEASE TREATED WITH ASPIRIN
Jako J. - ANALYSIS OF SURFACE AND SOLUBLE L-SELECTIN IN RELATION TO FLOW CYTOMETRIC PROGNOSTIC MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Jakovljevic B. - INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
Jakubowski J.A. - COMPARISON OF ANTIPLATELET AND ANTITHROMBOTIC EFFECTS OF PRASUGREL AND AZD6140
  - EFFECT OF PRASUGREL AND HIGH DOSE CLOPIDOGREL ON PLATELET FUNCTION AS ASSESSED BY POINT OF CARE AND OPTICAL AGGREGOMETRY
  - FLOW CYTOMETRIC ANALYSIS OF VASP PHOSPHORYLATION IN PLATELETS TREATED WITH THE ACTIVE METABOLITE OF PRASUGREL, A P2Y12 ADP RECEPTOR ANTAGONIST
  - INDIVIDUAL AND COMBINED EFFECTS OF ASPIRIN AND THIENOPYRIDINES IN ATTENUATION OF PLATELET AGGREGATION INDUCED BY COLLAGEN AND OTHER AGONISTS
  - COMPETITION BETWEEN REVERSIBLE AND IRREVERSIBLE P2Y12 ANTAGONISTS AND ITS INFLUENCE ON ADP-MEDIATED PLATELET ACTIVATION
  - GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
  - GREATER INHIBITION OF PLATELET ACTIVATION AND PLATELET-MONOCYTE COMPLEX FORMATION BY PRASUGREL COMPARED TO CLOPIDOGREL IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
  - P2Y12 BLOCKADE BY PRASUGREL ACTIVE METABOLITE YIELDS COMPLETE INHIBITION OF P2Y12-MEDIATED AMPLIFICATION OF PLATELET RESPONSES
Jalagadugula G.S. - PHORBOL 12-MYRISTATE 13-ACETATE (PMA) RESPONSIVE SEQUENCE IN G ALPHA Q PROMOTER DURING MEGAKAYOCYTIC DIFFERENTIATION: REGULATION BY EGR-1
  - IMPAIRED REGULATION OF PLATELET 12-LIPOXYGENASE (ALOX12) WITH CBFA2/RUNX1 HAPLODEFICIENCY
Jalali F. - VENOUS FUNCTION AND CLINICAL OUTCOME FOLLOWING DEEP VEIN THROMBOSIS
  - ASSESSMENT RISK FACTOR IN THE MANAGEMENT OF PATIENTS WITH SUSPECTED DEEP VENOUS THROMBOSIS
Jalali Far M. - THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
  - HIGH PREVALENCE OF ELEVATED FACTOR VIII IN IRANIAN PATIENT WITH IDIOPATHIC VENOUS THROMBOEMBOLISM
Jallu V. - GPIIB-IIIA INTEGRIN MUTATIONS IDENTIFIED IN 19 GLANZMANN THROMBASTENIC PATIENTS AND 3 CARRIERS
  - NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO RARE PLATELET ALLOANTIGENS
Jaloma A.R. - NATIONAL STUDY OF INHIBITOR KINETICS AND TREATMENT RESPONSE IN HEMOPHILIA A AND B MEXICAN PATIENTS
Jamalian N. - DETERMINATION OF PROTEIN C LEVEL IN NEONATES WITH SEPSIS LIKE ILLNESS
  - INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
Jámbor L. - A PILOT STUDY WITH AUTOLOGOUS BONE MARROW-DERIVED STEM CELL TRANSPLANTATION (ABSCT) IN PATIENTS WITH SEVERE PERIPHERAL ARTERIAL DISORDER (SPAD)
James A. - ANTIPHOSPHOLIPID ANTIBODY SYNDROME IN THE THROMBOPHILIA PILOT PROJECT
James P. - THE PREVALENCE OF SYMPTOMATIC VON WILLEBRAND DISEASE (VWD) IN PRIMARY CARE PRACTICE
James T.E. - GPVI IN THE PLASMA OF HEALTHY INDIVIDUALS AND PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), MEASURED BY A NOVEL ENZYME-LINKED IMMUNOSORBANT ASSAY
James S. - GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
James P. - THE EFFECT OF EXERCISE ON INDIVIDUALS WITH TYPE 1 AND TYPE 2B VON WILLEBRAND DISEASE (VWD)
  - DIAGNOSTIC EFFICACY OF SYSTEMATIC INVESTIGATION OF NON-VON WILLEBRAND BLEEDERS: RESULTS OF A PROSPECTIVE STUDY
James P.D. - CHALLENGES IN DEFINING TYPE 2M VON WILLEBRAND DISEASE: RESULTS FROM A CANADIAN COHORT STUDY
James S. - GREATER INHIBITION OF PLATELET ACTIVATION AND PLATELET-MONOCYTE COMPLEX FORMATION BY PRASUGREL COMPARED TO CLOPIDOGREL IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
James A. - THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: MATERNAL THROMBOPHILIA
James E.A. - C2 DOMAIN T-CELL EPITOPES IN HEMOPHILIA A SUBJECTS WITH THE MUTATION A2201P
James L.B. - HEPARIN-INDUCED PLATELET AGGREGATION DOES NOT PREDICT THE PRESENCE OF ANTI-HEPARIN ANTIBODIES
James P. - PLATELET TYPE VON WILLEBRAND DISEASE: AN UNDERDIAGNOSED CAUSE OF EXCESSIVE MUCOCUTANEOUS BLEEDING
James T.E. - TRANSIENT REVERSAL OF THE ANTI-PLATELET EFFECT OF ASPIRIN AFTER ADMINISTRATION OF UNFRACTIONATED HEPARIN IN HEALTHY SUBJECTS
James P.D. - THE ISTH SSC VON WILLEBRAND FACTOR (VWF) ONLINE DATABASE
James T.E.B. - CIRCADIAN VARIATION IN THE PLATELET RESPONSE AND THE EFFECT OF MELATONIN
Janatpour K.A. - COMPARISON OF PRE-TEST PROBABILITY SCORES TO COMMERCIAL ASSAYS FOR MEASURING ANTIBODIES ASSOCIATED WITH HEPARIN-INDUCED THROMBOCYTOPENIA
  - EVALUATION OF A PROTOTYPE MULTIPLEX METHOD FOR EVALUATING PHOSPHOLIPID ANTIBODIES
Janatpour K. - EXPLORING ADULT PATIENT POPULATIONS AT RISK FOR DEVELOPING HIT
Jandrot-Perrus M. - INCREASED PLASMA MARKERS OF PLATELET AND PROTHROMBIN ACTIVATION IN PATIENTS WITH THORACIC ASCENDING AORTIC ANEURYSM
  - COORDINATED ACTION OF GPVI AND FCRGAMMA CYTOPLASMIC DOMAINS IN SIGNALLING
  - EX VIVO ANTITHROMBOTIC EFFECTS OF ANTI GPVI FAB FRAGMENT IN NON-HUMAN PRIMATES WITHOUT MODIFICATION OF GPVI EXPRESSION
  - GENERATION AND CHARACTERIZATION OF A RECOMBINANT BLOCKING ANTI-GLYCOPROTEIN VI SINGLE CHAIN ANTIBODY FRAGMENT
  - ROLES OF THE C-TERMINAL TYROSINE RESIDUES OF LAT IN GPVI-INDUCED PLATELET ACTIVATION; INSIGHT INTO THE MECHANISM OF PLC GAMMA2 ACTIVATION
  - PAR4 INDUCES FULL PLATELET SPREADING ON A FIBRINOGEN MATRIX: INVOLVEMENT OF ERK2 AND P38 AND CA2+ MOBILIZATION
  - SPATIO-TEMPORAL CALCIUM SIGNALING ELICITED BY INTEGRIN ALPHA2-BETA1 AND GLICOPROTEIN VI UNDER FLOW
  - PROTEASE NEXIN-1 AND THROMBOMODULIN FORM COMPLEXES WITH A HIGHLY POTENT ANTI-THROMBIN ACTIVITY
  - MONOCYTES DOWN-REGULATE INITIAL PHASE OF COLLAGEN-INDUCED PLATELET ACTIVATION
Janes A. - PROTHROMBOTIC FACTORS IN INFANTS WITH NEONATAL CEREBRAL INFARCTION
Jang M.M.J. - CHANGES OF THE PLASMA LEVELS OF PLATELET AND ENDOTHELIAL MICROPARTICLES IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND ANTIHOSPHOLIPID SYNDROME
Jang S. - PREVALENCE OF ASPIRIN RESISTANCE MEASURED BY TWO RAPID PLATELET FUNCTION ANALYZERS
  - P2RY12 RECEPTOR POLYMORPHISMS (SNPS) IN PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION
  - CLINICAL EXPERIENCE WITH PLATELET AGGREGATION TESTING FOR ASPIRIN AND CLOPIDOGREL
Jang M.M.J. - EARLY DIAGNOSIS OF SEPTIC DISSEMINATED INTRAVASCULAR COAGULOPATHY
Jang S. - INDETERMINATE RESULTS ARE COMMON IN LUPUS ANTICOAGULANT TESTING
Jang R.C. - VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN TRANSFUSION-DEPENDENT THALASSEMIC PATIENTS: RELATION TO BLOOD TRANSFUSION
  - ELEVATED PLASMA FREE FATTY ACID LEVEL (MYRISTIC ACID, PALMITIC ACID, STEARIC ACID) IN TYPE 2 DIABETIC INDIVIDUAL
Jang Y. - DISINTEGRIN SUPPRESSES HUMAN VASCULAR ENDOTHELIAL CELL MIGRATION AND INVASION BY REGULATING PLATELET ACTIVATION
Jang S. - ESTABLISHMENT OF REFERENCE INTERVALS OF PLATELET FUNCTION ANALYZER-100 CLOSURE TIMES IN HEALTHY KOREAN ADULTS
Janisch S. - EVALUATION OF VWF CONCENTRATE ACTIVITY ASSAYS EMPLOYING COLLAGEN TYPES I AND III
  - VWF:RCO ASSAYS USING AUTOMATED SYSTEMS FOR VWF/FVIII CONCENTRATES REQUIRE ADJUSTMENT OF ASSAY REAGENTS, COMPOSITION AND PERFORMANCE PARAMETERS
  - THROMBIN GENERATION CAPACITY IS IMPAIRED IN METHYLENE-BLUE (MB) TREATED PLASMA UNITS COMPARED TO SINGLE-DONOR FFP, A PHARMACEUTICALLY LICENSED COAGULATION ACTIVE AND SOLVENT-DETERGENT (S/D) TREATED PLASMA PRODUCT AND A UNIVERSALLY APPLICABLE S/D-PLASMA UN
Jankovic G. - HAEMOPHILIA TREATMENT IN SERBIA FROM 2000 TO 2006 HOW TO REACH ONE UNIT PER CAPITA IN LOW ECONOMIC CAPACITY COUNTRY
Jankovicova D. - TORPID CLINICAL COURSE OF THROMBOTIC THROMBOCYTOPENIC PURPURA
  - FACTOR VIIII INHIBITOR IN SEVERE HEMOPHILIA A TREATED WITH PD-FVIII CONCENTRATES
  - BLEEDING AND THROMBOTIC MANIFESTATION IN 58 PATIENTS WITH CONGENITAL DYSFIBRINOGENEMIA
Jankowitz R.C. - RECOMBINANT IL-11 INCREASES VWF AND VWFMRNA IN TYPE 1 VWD
Jansen M. - ABSENCE OF INHIBITOR FORMATION IN PREVIOUSLY TREATED HAEMOPHILIA A PATIENTS TREATED WITH A DOUBLE VIRUS INACTIVATED, PLASMA DERIVED FACTOR VIII/VWF CONCENTRATE IN PROSPECTIVE CLINICAL STUDIES
  - LOW INCIDENCE OF INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS WITH HAEMOPHILIA A
  - CLINICAL EFFICACY AND SAFETY OF A NOVEL HIGH-PURITY, DOUBLE VIRUS-INACTIVATED VWF/FVIII-CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND DISEASE AN UPDATE ON THE CLINICAL PROGRAMME
  - EFFICACY AND SAFETY OF A HIGHLY PURIFIED FACTOR IX CONCENTRATE IN PAEDIATRIC PATIENTS WITH HAEMOPHILIA B - RESULTS OF A CLINICAL TRIAL AND A POST MARKETING SURVEILLANCE STUDY
Janssen M.C.H. - ELEVATED MARKERS OF INFLAMMATION IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS ARE A RISK FACTOR FOR ELEVATED VENOUS RESISTANCE AS A PROXY OF THE POST-THROMBOTIC SYNDROME
Janssen J. - THE DUAL ROLE OF INTRINSIC GENERATED PLASMIN IN THE REGULATION OF THE HEMOSTATIC BALANCE
Janssen M.C.H. - COMPRESSION BANDAGING IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS IN RELATION TO THE POST-THROMBOTIC SYNDROME
Janssen N.A.H. - EFFECTS OF PARTICULATE MATTER AIR POLLUTION ON INFLAMMATION AND HAEMOSTASIS
Janssens S. - CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS
Jaouen E. - CUTANEOUS REACTION TO LOW MOLECULAR WEIGHT HEPARIN AND HOMOZYGOUSIS FOR FACTOR V LEIDEN MUTATION DURING PREGNANCY: A CASE REPORT
Jarchum G. - PAI-1 GENE 4G/5G GENOTYPE AS AN ADDITIONAL RISK FACTOR IN PATIENTS WITH THROMBOSIS: A RETROSPECTIVE COHORT STUDY
  - ANTICOAGULATION IN A PATIENT WITH SEVERE PREECLAMPSIA, POSITIVE ANTIBETA2-GLYCOPROTEIN I ANTIBODIES AND HOMOZIGOSITY FOR PAI-1 AND MTHFR
Jardin I. - A ROLE FOR SNAP-25 IN THROMBIN-INDUCED PLATELET AGGREGATION
  - RELEVANCE OF CA2+ ENTRY TO PLATELET AGGREGATION BY ACTIVATION OF THROMBIN RECEPTORS
Jarosch-Preusche M. - ARE PATIENTS WITH THROMBOPHILIA AND A HISTORY OF VENOUS THROMBOEMBOLISM AT HIGHER RISK TO ARTERIAL THROMBOTIC EVENTS?
  - MALE GENDER INCREASES RISK OF VTE RECURRENCE AFTER SPONTANEOUS AND RISK-ASSOCIATED FIRST VENOUS THROMBOEMBOLISM
Jarvis G.E. - PLATELET RECEPTOR RECOGNITION AND CROSSTALK IN COLLAGEN-INDUCED ACTIVATION OF PLATELETS
  - IDENTIFICATION OF CRITICAL RESIDUES IN A GPVI BINDING PEPTIDE
Jasper S.E. - ANTICOAGULANT RESPONSES IN PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN COMPARED TO UNFRACTIONATED HEPARIN FOR TEE GUIDED CARDIOVERSION OF ATRIAL FIBRILLATION: RESULTS FROM THE ASSESSMENT OF CARDIOVERSION USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY (ACUTE
Jaulmes A. - NOX4 IS STRONGLY INVOLVED IN ENDOTHELIAL PAI-1 SYNTHESIS
Jaussent A. - SYMPTOMATIC THROMBOSIS COMPLICATIONS IN VENOUS MALFORMATION
Javillo J. - DO WE COMPLETELY UNDERSTAND THE ANTITHROMBOTIC EFFECT OF ASPIRIN?
Jay R. - CLINICALLY - IMPORTANT VENOUS THROMBOEMBOLISM (CIVTE) FOLLOWING ISOLATED LEG FRACTURES DISTAL TO THE KNEE: EPIDEMIOLOGY AND PREVENTION: THE D-KAF (DALTEPARIN IN KNEE TO ANKLE FRACTURE) TRIAL
  - INACCURACY OF POINT-OF-CARE (POC) WHOLE BLOOD INR AT INR VALUES GREATER THAN 4
Jayasuriya K. - COVALENT ANTITHROMBIN-HEPARIN COMPLEX NEUTRALIZES PROCOAGULANT ACTIVITY INDUCED BY VENTILATION IN NEWBORNS
Jayle C. - ASPIRIN PREVENTS PLATELET ACTIVATION AFTER CORONARY ARTERY BYPASS SURGERY DESPITE AN INCREASE IN THROMBOXANE A2 SYNTHESIS
  - INCIDENCE OF ANTITHROMBIN LEVEL ON "HEMOFILTER CIRCUIT" THROMBOSIS DURING EARLY CONTINUOUS VENOVENOUS HEMOFILTRATION IN POST CARDIOPULMONARY BYPASS PATIENTS
Jazebi M. - EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
  - GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
  - A NOVEL CANDIDATE A/T789P MUTATION IDENTIFIED IN FIVE PATIENTS WITH TYPE 2N VON WILLEBRAND DISEASE FROM TWO DIFFERENT FAMILIES
  - EPIDEMIOLOGY OF BERNARD SOULIER DISEASE
  - GENETIC ANALYSIS OF BERNARD SOULIER PATIENTS IN IRAN: REPORT OF FIVE NOVEL MUTATIONS
  - THROMBOSIS IN BETA THALASSEMIA MAJOR
  - VON WILLEBRAND DISEASE TYPES 2A MUTATION (C.4789CT, P.R1597W) IN THREE IRANIAN PATIENTS
Jean A. - MONOCYTE PARAMETERS TO DISCRIMINATE ESSENTIAL FROM REACTIVE THROMBOCYTOSIS
Jeimy S.B. - PLATELET FACTOR V DEFICIENCY IN A PATIENT WITH AN ACQUIRED INHIBITOR OF VA PROCOAGULANT FUNCTION
  - THE ROLE OF THE FACTOR V B DOMAIN IN FACTOR V-MMRN1 BINDING AND DISSOCIATION
Jeng J.H. - INDUCTION OF PLATELET AGGREGATION BY SAS CANCER CELLS A MECHANISM FOR HEMATOGENOUS METASTASIS OF TONGUE CANCER
  - ANTIPLATELET EFFECTS OF HYDROXYCHAVICOL, A BETEL LEAF COMPONENT
Jenkins J.M. - ELTROMBOPAG, THE ORAL PLATELET GROWTH FACTOR, INCREASED PLATELET COUNT AND DID NOT AFFECT PLATELET FUNCTION WHEN ADMINISTERED TO HEALTHY MALE SUBJECTS
Jenkins V. - RECURRENCE OF THE FACTOR VIII GENE R531H MUTATION IN 13 IRISH FAMILIES: EVIDENCE FOR A FOUNDER EFFECT
Jenkinson H. - USING A PROTEOMIC APPROACH TO IDENTIFY SPECIFIC STREPTOCOCCAL PROTEINS RESPONSIBLE FOR INDUCING PLATELET AGGREGATION IN INFECTIVE ENDOCARDITIS
  - A NOVEL GPIB ALPHA BINDING PROTEIN ON STREPTOCOCCUS GORDONII INDUCES PLATELET ROLLING AT LOW SHEAR
Jennersjö C. - DOES THROMBIN GENERATION OR D-DIMER VALUES AT TIME OF AN ACUTE EVENT OF VENOUS THROMBO-EMBOLISM PREDICT RECURRENCES?
Jennings I. - SOURCE AND USE OF REFERENCE RANGES IN HAEMOSTASIS: PRACTICE AMONGST UK NEQAS FOR BLOOD COAGULATION PARTICIPANTS 2005-6
Jennings L.K. - GPIIB-IIIA ANTAGONISTS HAVE A SIGNIFICANT EFFECT ON THROMBUS STABILITY BY DISPLACING BOUND FIBRINOGEN
Jennings I. - IMPLEMENTING AN EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR USERS OF COAGUCHEK XS AND COAGUCHEK XS PLUS FOR MONITORING INRS
Jennings N. - PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
Jennings I. - THE UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME (UK NEQAS) FOR MOLECULAR GENETIC TESTING IN HAEMOPHILIA
  - DIFFERENCES IN THROMBOPHILIA ASSAY RESULTS BETWEEN COMMERCIAL REFERENCE PLASMAS USING THE SSC/ISTH SECONDARY COAGULATION STANDARD LOT#3 IN UK NEQAS FOR BLOOD COAGULATION PROFICIENCY TESTING EXERCISES
  - AN EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR PATIENT SELF-TESTING FOR MONITORING INRS- 2 YEARS OF RESULTS
Jennings L.K. - TETRASPANIN CD9 MODULATES VASCULAR SMOOTH MUSCLE CELL MIGRATION AND PROLIFERATION IN VITRO AND NEOINTIMA FORMATION IN VIVO
Jennings I. - THE SSC/ISTH SECONDARY COAGULATION STANDARD LOT#3 IN UK NEQAS FOR BLOOD COAGULATION PROFICIENCY TESTING EXERCISES: MARKED DIFFERENCES IN FV AND FXI RESULTS BETWEEN COMMERCIAL REFERENCE PLASMAS
Jennings L.K. - TYROSINE KINASE SYK PLAYS A PIVOTAL ROLE IN PLATELET SIGNALING INITIATED BY PATHOPHYSIOLOGICAL SHEAR STRESS
Jennings I. - VARIABILITY IN ANTICOAGULANT DOSING RECOMMENDATIONS; RESULTS FROM TWO UK NEQAS FOR BLOOD COAGULATION EXERCISES
Jensen R.B. - IMPROVED PROCOAGULANT AND PHARMACOKINETIC PROPERTIES OF TWO NOVEL RECOMBINANT HUMAN FACTOR VIIA VARIANTS PREPARED BY DIRECTED MOLECULAR EVOLUTION AND RATIONAL DESIGN
Jensen A.L. - PROSPECTIVE DESIGN OF A NEW, OBJECTIVE SCORING SYSTEM FOR IDENTIFYING DISSEMINATED INTRAVASCULAR COAGULATION IN DOGS A SPONTANEOUS ANIMAL MODEL
Jensen T. - FIBRINOGEN AND FIBRIN INDUCE SYNTHESIS OF PROINFLAMMATORY CYTOKINES FROM PERIPHERAL BLOOD MONONUCLEAR CELLS
Jensen E.S. - CORRECTION OF HAEMORRHAGIC DISORDERS AFFECTING PLATELETS: GENE THERAPY RESTORES HEMOSTASIS WITHIN A CANINE MODEL FOR GLANZMANN THROMBASTHENIA
Jensen S.S. - STRATEGIES FOR CHARACTERIZING THE PHOSPHO- AND GLYCOPROTEOMES OF MICROPARTICLES DERIVED FROM INTERLEUKIN-1BETA STIMULATED PANCREATIC BETA-CELLS
Jensen D. - KLF4, A MODIFIER GENE IN GP6-NULL MICE
Jensen E. - SAFETY AND TOLERABILITY OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN PREVENTION OF STROKE AND OTHER THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION (AF)
  - CPU INHIBITION WITH AZD9684: PROFIBRINOLYTIC EFFECTS IN ACUTE PE PATIENTS
Jeon O. - DISINTEGRIN SUPPRESSES HUMAN VASCULAR ENDOTHELIAL CELL MIGRATION AND INVASION BY REGULATING PLATELET ACTIVATION
Jeong Y. - PREVALENCE OF ASPIRIN RESISTANCE MEASURED BY TWO RAPID PLATELET FUNCTION ANALYZERS
Jerabek I. - REGULATION OF PROTEIN C INHIBITOR (PCI) ACTIVITY BY OXIDIZED AND NEGATIVELY CHARGED PHOSPHOLIPIDS
Jerczynska H. - DIAMOND PARTICLES OF MICROMETRIC SIZE ARE INTERNALIZED BY ENDOTHELIAL CELLS
  - EFFECT OF NATRIURETIC PEPTIDES ON ANGIOGENIC PROPERTIES OF HUMAN ENDOTHELIAL CELLS
Jerling J.C. - THE EFFECT OF FIBRINOGEN GLYCATION ON FIBRIN NETWORK STRUCTURE OF TYPE II DIABETIC SUBJECTS
Jern S. - IL-1BETA-INDUCED TISSUE-TYPE PLASMINOGEN ACTIVATOR SUPPRESSION IN VASCULAR ENDOTHELIAL CELLS IS MEDIATED BY NF-KAPPAB SIGNALING
Jern C. - FIBRINOGEN HAPLOTYPES AND PLASMA LEVELS SHOW INDEPENDENT ASSOCIATION TO ISCHEMIC STROKE
Jerome C. - HIGH DOSES OF RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A HEMOPHILIA A PATIENT WITH INHIBITOR
Jeske W.P. - UPREGULATION OF MICROPARTICLES IN HEPARIN INDUCED THROMBOCYTOPENIA (HIT) AND IT'S MODULATION BY ARGATROBAN
  - PLATELET-BOUND PF4 IS TARGETED BY HIT ANTIBODIES IN THE ABSENCE OF HEPARIN
  - UPREGULATION OF NITRIC OXIDE AND ASYMMETRIC DIMETHYLARGININE LEVELS IN MALIGNANCY ASSOCIATED THROMBOSIS AND THEIR MODULATION BY ANTICOAGULANTS
  - DIFFERENTIAL ACTIVATION OF PROTHROMBIN BY FACTOR XA, TAIPAN VENOM AND ECARIN. PHARMACOLOGIC IMPLICATIONS
  - RECOMBINANT THROMBOMODULIN DOES NOT CROSS REACT WITH ANTI-HEPARIN PLATELET FACTOR 4 ANTIBODIES. POTENTIAL IMPLICATION FOR ANTICOAGULATION OF HEPARIN-INDUCED THROMBOCYTOPENIA PATIENTS
  - TRYPSIN MEDIATED ACTIVATION OF THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR (CARBOXYPEPTIDASE U)
  - DEFIBROTIDE MEDIATED INHIBITION OF HEPARINASE I. POTENTIAL CLINICAL IMPLICATIONS
  - THE PHARMACOKINETICS OF DEFIBROTIDE IN NON-HUMAN PRIMATES IS DOSE DEPENDENT
  - DIFFERENCES IN THE OLIGOSACCHARIDE COMPOSITION OF GENERIC VERSIONS OF ENOXAPARIN AND DALTEPARIN
  - DOWN REGULATION OF THROMBOTIC AND INFLAMMATORY MEDIATORS IN PATIENTS WITH ACUTE CORONARY SYNDROME TREATED WITH CLOPIDOGREL. RELEVANCE TO THE OBSERVED CLINICAL EFFECTS
Jeske W. - DEFIBROTIDE AND ITS MOLECULAR FRACTIONS DO NOT CROSS-REACT WITH HIT ANTIBODIES. IMPLICATIONS IN THE MANAGEMENT OF HIT
Jeske W.P. - POTENTIAL OF THE FACTOR XA INHIBITOR RIVAROXABAN FOR THE ANTICOAGULATION MANAGEMENT OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
  - DIFFERENTIATION OF LOW MOLECULAR WEIGHT HEPARINS AS STUDIED BY MOLECULAR WEIGHT PROFILE AND HEPARINASE-I DEPOLYMERIZATION: PHARMACOLOGIC IMPLICATIONS
  - EVALUATION OF ALLOSTERIC INHIBITORS OF PAR1 ON PLATELET ACTIVATION
Jeske W. - UPREGULATION OF INFLAMMATORY MEDIATORS IN LUNG CANCER AND THEIR MODULATION BY ORAL ANTICOAGULANT THERAPY
Jeske W.P. - PROTEINOMIC PROFILING OF TISSUE FACTOR MEDIATED PROTHROMBIN ACTIVATION PRODUCTS AND THEIR INHIBITION BY DIRECT ANTITHROMBIN AND ANTI-XA AGENTS
  - GENERIC VERSIONS OF BRANDED LOW MOLECULAR WEIGHT HEPARINS CAN BE DIFFERENTIATED IN BIOLOGIC AND PHARMACOLOGIC ASSAYS
  - DIFFERENTIAL EFFECTS OF FXA INHIBITORS AND HEPARINS IN SIMULATED ARTERIAL AND VENOUS THROMBOSIS
Jesmok G.J. - EVALUATION OF PEG-FVIII MOLECULES WITH PROLONGED HALF-LIVES IN A MURINE FVIII-DEPENDENT BLEEDING MODEL
  - COMPARISON OF HUMAN RFVIII AND MURINE RFVIII IN A STANDARDIZED FVIII DEPENDENT BLEED MODEL IN FVIII -/- MICE
Jespersen J. - COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE
  - EXTERNAL QUALITY CONTROL FOR THE COAGUCHEK INR MEASUREMENT IMPORTANT TO CONTROL TEST STRIP QUALITY: EVIDENCE FOR LIMITED PROPORTIONAL DIFFERENCES
  - A NATIONAL FIELD STUDY OF QUALITY ASSESSMENT (QA) OF COAGUCHEK MONITORS
  - QUALITY ASSESSMENT OF COAGUCHEK MONITORS: COMPARATIVE ANALYSIS OF THE ECAA AND CONVENTIONAL EXTERNAL QA
  - COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY
  - LOCAL ISI CALIBRATION AND "DIRECT INR" IN CORRECTION OF REPORTED INTERNATIONAL NORMALISED RATIOS: AN INTERNATIONAL STUDY
Ji X.B. - THE CONSTRUCTION OF A HUMANIZED PHAGE ANTIBODY LIBRARY OF ANTI-PLATELET GPIIB/IIIA SINGLE CHAIN FV
  - PHENOTYPE AND FUNCTION OF CD4+CD25+ REGULATORY T CELLS IN MOUSE MODEL OF EXPERIMENTAL TRANSIENT IMMUNE THROMBOCYTOPENIA AFTER TREATMENT WITH INDIRUBIN
Jiang J. - THE INFLUENCE OF THE HEMODIALYSIS PROCEDURES ON PLATELET AND HEMOSTATIC FUNCTIONS
Jiang H. - LOSS OF SEMA4D SIGNALING BETWEEN PLATELETS DESTABILIZES ARTERIAL THROMBI AND REDUCES MYOCARDIAL INFARCT SIZE
  - EVALUATION OF PEG-FVIII MOLECULES WITH PROLONGED HALF-LIVES IN A MURINE FVIII-DEPENDENT BLEEDING MODEL
  - SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
Jiang X. - BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII
Jiang J. - EXPRESSION OF MT1-MMP IN HUMAN VASCULAR ENDOTHELIAL CELL LINES AND THE CONSTRUCTION OF ITS EUKARYOTIC EXPRESSION VECTOR
Jiang X.C. - THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES
Jiang Y. - IDENTIFICATION OF GENETIC SEQUENCES CORRESPONDING TO FACTORS V AND VIII IN A LAMPREY TRACE DATABASE
Jianguoi J. - CBL-B: A PHYSIOLOGICALLY IMPORTANT SIGNALING MOLECULE FOR COLLAGEN-DEPENDENT ACTIVATION
Jiao W. - HEREDITARY COAGULATION FACTOR XIII DEFICIENCY CAUSED BY A DELETION MUTATION OF F13A GENE
Jilma B. - STATINS INHIBIT LPS-INDUCED MONOCYTE-ASSOCIATED, BUT NOT PLATELET- OR MICROPARTICLE-ASSOCIATED TISSUE FACTOR (TF) EXPRESSION IN VIVO AND EX VIVO
  - THE EFFECT OF BIBT 986, A NOVEL SMALL MOLECULE DUAL INHIBITOR OF THROMBIN AND FACTOR XA, ON COAGULATION IN A MODEL OF ENDOTOXIN INDUCED, TISSUE FACTOR TRIGGERED COAGULATION ACTIVATION IN HUMANS
  - ETHNIC DIFFERENCES IN A HUMAN MODEL OF TISSUE FACTOR- TRIGGERED COAGULATION
  - EFFECTS OF LOW DOSE ENDOTOXEMIA ON ENDOTHELIAL PROGENITOR CELLS IN HUMANS
  - EFFECTS OF SHORT TERM STATIN PRE-TREATMENT AND SUBSEQUENT LOW DOSE ENDOTOXEMIA ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS
Jim J. - RECURRENT DEEP VEIN THROMBOSIS (DVT) IS EXCLUDED BY A NEGATIVE D-DIMER OR SERIAL COMPRESSION ULTRASONOGRAPHY (CUS): RESULTS OF A MULTICENTER MANAGEMENT STUDY
Jimenez D. - DEEP VEIN THROMBOSIS AND THE RISK OF RECURRENT PULMONARY EMBOLISM
Jimenez Sanguino S. - SURGICAL REMOVAL OF A PSEUDOTUMOR IN A PATIENT WITH HEMOPHILIA A AND INHIBITORS: A COLOMBIAN CASE STUDY
Jimenez Yuste V. - PRIMARY KNEE ARTHOPLASTY USING RECOMBINANT FACTOR VIIA (RFVIIA) AS FIRST-LINE THERAPY IN HAEMOPHILIA PATIENTS WITH HIGH RESPONDING INHIBITORS
  - IMMUNE TOLERANCE INDUCTION WITH VIII-CONTAINING FACTOR VWF
Jimenez-Caballero E. - RADIOSYNOVIORTHESIS IS NECESSARY IN HEMOPHILIC PATIENTS DESPITE PROHYLAXIS
Jimenez-Yuste V. - RADIOSYNOVIORTHESIS IS NECESSARY IN HEMOPHILIC PATIENTS DESPITE PROHYLAXIS
Jiménez-Yuste V. - SURGERY IN HEMOPHILIA PATIENTS WITH INHIBITORS: REPORT OF 91 SURGICAL PROCEDURES
Jin J. - RHOA/P160ROCK PLAYS AN IMPORTANT ROLE IN THE DENSE GRANULE RELEASE OF PLATELETS
Jin Y. - CERAMIDE KINASE/CERAMIDE 1-PHOSPHATE IS AN IMPORTANT REGULATOR ON AORTIC VASCULAR SMOOTH MUSCLE CELL PROLIFERATION
Jin P. - 8 NOVEL MUTATIONS IDENTIFIED GLANZMANN THROMBASTHENIA FAMILIES FROM CHINA
  - GENETIC ANALYSIS OF HEREDITARY PROTEIN S DEFICIENCY IN TWO CHINESE PEDIGREES
Jin Y. - ANTIPROLIFERATIVE ACTIVITY OF YQN1, A NEWLY SYNTHESIZED INDOLEDIONE DERIVATIVE, ON PDGF-BB-STIMULATED AORTIC VASCULAR SMOOTH MUSCLE CELLS
Jin P. - THREE NOVEL MUTATIONS OF ANTITHROMBIN GENE WERE IDENTIFIED IN CHINESE FAMILIES
Jin Y. - EMODIN INHIBITS PDGF-BB-STIMULATED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY BLOCKING OF PDGF BETA-RECEPTOR PHOSPHORYLATION
Jin P. - FUNCTIONAL ANALYSES OF THE LEU752ARG AND GLN891STOP ASSOCIATED WITH GLANZMANN THROMBASTHENIA
Jin Y. - ANTIPLATELET ACTIVITY OF EPIGALLOCATECHIN GALLATE IS MEDIATED BY THE INHIBITION OF PLCGAMMA2 PHOSPHORYLATION, ELEVATION OF PGD2 PRODUCTION AND MAINTENANCE OF CALCIUM-ATPASE PUMP
  - OBOVATOL INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMAL FORMATION AFTER CAROTID INJURY IN RATS
  - ANTIPLATELET ACTIVITY OF FENOFIBRATE, A PPARALPHA AGONIST, WAS MEDIATED BY BLOCKING OF CYTOSOLIC CALCIUM MOBILIZATION AND THROMBOXANE A2 RECEPTOR
Jin W. - A ROLE FOR GEMS IN PLATELET GLYCOPROTEIN IB-MEDIATED PLATELET ACTIVATION
Jin P. - FACTOR V MUTATIONS, SER234LEU AND ARG413CYS, ARE ASSOCIATED WITH FACTOR V DEFICIENCY AND A BLEEDING TENDENCY
Jin Y. - EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS
Jin P. - ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATED WITH MULTIPLE COAGULATION FACTOR DEFICIENCY IN SEVEN CHINESE PATIENTS
Jinca C. - HEMOSTATIC EXPRESSION OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN
Jiskoot W. - THE USE OF TISSUE-TYPE PLASMINOGEN ACTIVATOR TO DETECT MISFOLDED PROTEINS IN BIOPHARMACEUTICALS
Jobe S.M. - CRITICAL ROLE FOR CYCLOPHILIN D (CYPD) AND THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (MPTP) IN THE REGULATION OF PLATELET ACTIVATION AND THROMBOSIS
Jobes D. - EVALUATION OF THE POINT OF CARE MICRO-COAGULATION TESTS IN PEDIATRICS
Jochmans K. - DIAGNOSTIC ACCURACY OF THE TRIAGE D-DIMER TEST FOR EXCLUSION OF VENOUS THROMBOEMBOLISM IN OUTPATIENTS
  - IDENTIFICATION OF TWO DE NOVO ANTITHROMBIN TYPE I MUTATIONS
  - SUCCESSFUL PREGNANCY OUTCOME IN A WOMAN WITH HOMOZYGOUS ANTITHROMBIN DEFICIENCY (99 LEUPHE MUTATION)
Joel A. - THROMBIN GENERATION AND THE TYPE OF ANTITHROMBIN DEFICIENCY
Joergensen M. - LOCAL THROMBOLYTIC THERAPY FOR ACUTE ILIOFEMORAL DEEP VENOUS THROMBOSIS IS EFFECTIVE AND PRESERVES VENOUS VALVE FUNCTION. A PROSPECTIVE ONE-CENTRE STUDY OF 86 CASES
Johannesen N.L. - TEST OF ASPIRIN RESISTANCE
Johansen K.B. - ANTITHROMBOTIC EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN IN HYPERCOAGULATION STATES AND CANCER-ASSOCIATED THROMBOSIS
  - RENAL ELIMINATION OF TINZAPARIN VERSUS ENOXAPARIN IN NORMAL VERSUS NEPHRECTOMIZED RATS
Johansen K. - OLIGOSACCHARIDES FROM DIFFERENT LOW MOLECULAR WEIGHT HEPARINS HAVE DIFFERENT ANTICOAGULANT AND PROTAMINE SULPHATE NEUTRALIZATION PROFILES
Johansen K.B. - ANTI-METASTASIS EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN IN EXPERIMENTAL METASTASIS MODEL
  - EFFECT OF LOW MOLECULAR WEIGHT HEPARIN ON ANGIOGENESIS
  - EFFECT OF LOW MOLECULAR WEIGHT HEPARIN ON HUMAN ENDOTHELIAL TISSUE FACTOR PATHWAY INHIBITOR RELEASE
  - ANTI-CANCER EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN IN THROMBOSIS-ASSOCIATED TUMOR GROWTH
Johansson M. - INCREASED PLATELET PROCOAGULANT ACTIVITY IN TYPE 2 DIABETIC PATIENTS: INHIBITION BY GPIIB/IIIA BLOCKADE
Johansson P.I. - COMBINED EFFECTS OF RFVIIA AND RFXIII ON CLOT FORMATION AND STABILITY IN PLASMA AND BLOOD FROM NORMAL DONORS AND FROM THROMBOCYTOPENIC PATIENTS
  - PROSPECTIVE DESIGN OF A NEW, OBJECTIVE SCORING SYSTEM FOR IDENTIFYING DISSEMINATED INTRAVASCULAR COAGULATION IN DOGS A SPONTANEOUS ANIMAL MODEL
Johansson B. - ASSESSMENT OF THE ELECTROPHYSIOLOGICAL EFFECTS OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837, IN SUBJECTS UNDERGOING AN INVASIVE ELECTROPHYSIOLOGICAL PROCEDURE
Johnell M. - GREATER INHIBITION OF PLATELET ACTIVATION AND PLATELET-MONOCYTE COMPLEX FORMATION BY PRASUGREL COMPARED TO CLOPIDOGREL IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
  - GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
  - TISSUE FACTOR/FACTOR VIIA COMPLEX REGULATES PDGF-BB-INDUCED CHEMOTAXIS THROUGH SRC FAMILY KINASE SIGNALING
Johnsen S.P. - EPIDEMIOLOGICAL STUDY OF VENOUS THROMBOEMBOLISM IN A BIG DANISH COHORT
Johnson J.V. - EFFECTS OF ORAL (OC) AND TRANSDERMAL (TC) HORMONAL CONTRACEPTION ON COAGULATION FACTORS AND ACTIVATED PROTEIN C RESISTANCE: IMPLICATIONS FOR THROMBOSIS RISK
Johnson D.J.D. - THE MECHANISM OF ALLOSTERIC ACTIVATION OF ANTITHROMBIN REVEALED BY CRYSTAL STRUCTURES OF ITS MONOMERIC AND FACTOR XA-COMPLEXED FORMS
Johnson G.J. - THE CRITICAL ROLE OF MYOSIN IIA IN PLATELET INTERNAL CONTRACTION
Johnson K.W. - NON-ANTICOAGULANT SULFATED POLYSACCHARIDES ENHANCE THROMBIN GENERATION BY ACCELERATING FACTOR V ACTIVATION
Johnson D.J.D. - THROMBIN IS A ZYMOGEN-LIKE ENZYME
Johnson K.W. - PRECLINICAL PHARMACOLOGY OF AV513 INCLUDING ORAL EFFICACY IN SEVERE HEMOPHILIA A DOGS
Johnson G.J. - INCREASED CELL ASSOCIATED TISSUE FACTOR ACTIVITY FOLLOWING TOTAL KNEE ARTHROPLASTY
Johnson G. - A CALCIUM-DEPENDENT PROTEASE CLEAVES VWF73 AT THE PEPTIDE BOND CORRESPONDING TO V1607-T1608 IN THE A2 DOMAIN
Johnson G.J. - TISSUE FACTOR PROCOAGULANT ACTIVITY LEVELS IN HUMAN BLOOD ARE ELEVATED BY WARFARIN
Johnson S.C. - RARE ANTIGENS IN NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
Johnson K.W. - AV513 ENHANCES TISSUE FACTOR ACTIVITY AND STIMULATES THROMBIN GENERATION IN HEMOPHILIA A PLASMA
Johnson C.L. - MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
Johnson M.S. - PLATELET INTEGRIN ALPHA2BETA1 INTERACTION WITH TYPE I COLLAGEN IS INHIBITED BY A NOVEL SYNTHETIC MOLECULE BTT-3016
Johnson A.J. - RAISED LEVELS OF CD39 IN LEUCOCYTOSIS RESULT IN MARKED INHIBITION OF ADP-INDUCED PLATELET AGGREGATION VIA RAPID ADP HYDROLYSIS
Johnston K.A. - CANCER-ASSOCIATED THROMBOSIS: TISSUE FACTOR-BEARING MICROPARTICLES ARE ASSOCIATED WITH AN INCREASED RISK OF VENOUS THROMBOEMBOLIC EVENTS IN CANCER PATIENTS
Johnston L. - UNFRACTIONATED HEPARIN (UFH) PHARMACOKINETICS IN CHILDREN
  - POTENTIAL USE OF AUTOMATED THROMBIN CLOTTING TIME (TCT) ASSAY FOR MONITORING UFH THERAPY
Johnston M. - COMPARISON OF IMPEDANCE WHOLE BLOOD AGGREGATION AND OPTICAL PLATELET-RICH PLASMA AGGREGATION TO MEASURE THE ANTIPLATELET EFFECT OF ASPIRIN IN HEALTHY CONTROLS AND IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD)
Johnston L. - UFH PHARMACOLOGY IN CHILDREN
Johnston M. - COMPARISON OF THE ASSERACHROM VON WILLEBRAND FACTOR ANTIGEN ASSAY AND THE LIATEST VWF ASSAY AUTOMATED ON THE AMAX 200 COAGULATION ANALYZER IN HUMAN AND CANINE PLASMA SAMPLES
  - COMPARISON OF TWO ASSAYS FOR THE MEASUREMENT OF URINARY 11-DEHYDRO THROMBOXANE B2
Joing M. - TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL
Jokar N. - INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
Jondeau G. - INCREASED PLASMA MARKERS OF PLATELET AND PROTHROMBIN ACTIVATION IN PATIENTS WITH THORACIC ASCENDING AORTIC ANEURYSM
Jones F. - RECURRENCE OF THE FACTOR VIII GENE R531H MUTATION IN 13 IRISH FAMILIES: EVIDENCE FOR A FOUNDER EFFECT
Jones C.I. - INHERENT VARIATION INDONOR PLATELET REACTIVITY CONTRIBUTES TO THE QUALITY OF APHERESIS PLATELETS
  - ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
Jones S. - TACHYKININS AND THE NEUROKININ RECEPTOR 1 ARE REQUIRED FOR PLATELET THROMBUS FORMATION
Jones D.W. - HUMAN VASCULAR ENDOTHELIAL CELLS INFLUENCE THE WHOLE BLOOD THROMBIN GENERATION ASSAY
Jones L.A. - POISONING WITH SUPERWARFARIN
Jones C.I. - PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
  - THE EFFECT OF APHERESIS ON DONORS' PLATELETS
  - NOVEL PLATELET TRANSMEMBRANE PROTEINS: IDENTIFICATION AND ANALYSIS
Jones B. - BLEEDING AND THROMBOTIC COMPLICATIONS OF LIVER TRANSPLANTATION IN CHILDREN
  - CHANGES IN HAEMOSTATIC FACTORS DURING AND AFTER LIVER TRANSPLANTATION IN CHILDREN
Jones D.W. - WHOLE BLOOD AND PLASMA THROMBIN GENERATION ASSAYS IN PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM
Jones C.I. - TRANSIENT REVERSAL OF THE ANTI-PLATELET EFFECT OF ASPIRIN AFTER ADMINISTRATION OF UNFRACTIONATED HEPARIN IN HEALTHY SUBJECTS
  - DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
Jones M.L. - PROTEOMIC ANALYSIS OF THE SHP-1 INTERACTOME IN HUMAN PLATELETS
Jones C.I. - REGULATION OF THE PLATELET PROCOAGULANT RESPONSE
Jong G. - THE ROLES OF SERUM MATRIX METALLOPROTEINASES IN PATIENTS WITH CORONARY ARTERY DISEASE AND ATRIAL FIBRILLATION TO HEART FAILURE
  - THE ROLES OF TUMOR NECROSIS FACTOR-? AND CELL ADHESION MOLECULES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND HEART FAILURE
Jonson B. - EARLY HOME THERAPY AND OUTCOME AMONG 675 PATIENTS WITH PULMONARY EMBOLISM
Joø G.B. - FIBRINOGEN AND FIBRIN INDUCE SYNTHESIS OF PROINFLAMMATORY CYTOKINES FROM PERIPHERAL BLOOD MONONUCLEAR CELLS
Jood K. - FIBRINOGEN HAPLOTYPES AND PLASMA LEVELS SHOW INDEPENDENT ASSOCIATION TO ISCHEMIC STROKE
Jørgensen L. - FREQUENCY AND TIME OF ONSET OF ACUTE MYOCARDIAL INFARCTION IN SUDDEN UNEXPECTED DEATHS IN A FORENSIC AUTOPSY MATERIAL
  - PLATELET DEPOSITION IN RABBIT COMMON CAROTID ARTERIES PROMOTED BY ARTERIAL STENOSIS AND SPASM
Jörneskog G. - FIBRIN GEL POROSITY RELATES TO GLYCOSYLATED HAEMOGLOBIN IN PATIENTS WITH TYPE 1 DIABETES
  - FIBRIN GEL POROSITY: COMPARISON OF TWO LABORATORY ASSAYS
Jorneskog G. - DOES ANGIOTENSIN II HAVE PROINFLAMMATORY OR PROTHROMBOTIC EFFECTS?
Jorquera J.I. - COLLAGEN AFFINITY TO VON WILLEBRAND FACTOR CONTAINED IN A THERAPEUTIC FVIII/VWF CONCENTRATE EVALUATED BY SURFACE PLASMON RESONANCE
  - CAPACITY OF SOLVENT-DETERGENT TREATMENT AND NANOFILTRATION APPLIED TO FVIII/VWF AND FIX PURIFICATION PROCESSES TO ELIMINATE EMERGING VIRAL PATHOGENS
  - EVALUATION BY SURFACE PLASMON RESONANCE OF VWF EFFECT ON MONOCLONAL ANTIBODY DIRECTED TO FVIII LIGHT CHAIN REACTIVITY
  - THROMBIN GENERATION ASSAY (TGA) CORRECTION IN VITRO AFTER ADDITION OF THERAPEUTIC RANGE DOSES OF PROTHROMBIN COMPLEX CONCENTRATE (PCC) TO PLASMA SAMPLES WITH INR 5
  - HEPARIN AFFINITY CHROMATOGRAPHY AND ADDITIONAL PURIFICATION STEPS EFFECTIVELY ELIMINATE AN EXPERIMENTAL TSE-MODEL AGENT SPIKED INTO FACTOR VIII/VWF PRODUCTION PROCESS
  - NANOFILTRATION APPLIED TO FACTOR IX PURIFICATION PROCESS EFFECTIVELY ELIMINATES AN EXPERIMENTAL TSE-MODEL AGENT
  - STABILITY OF HIGH PURITY THERAPEUTIC FVIII/VWF CONCENTRATE AFTER RECONSTITUTION
Joschko K. - LOW MOLECULAR WEIGHT HEPARIN IN PREGNANCY - INFLUENCE ON BIRTH WEIGHT AND DURATION OF PREGNANCY IN WOMEN WITH THROMBOPHILIA
Jose M. - THROMBIN GENERATION ASSAY (TGA) CORRECTION IN VITRO AFTER ADDITION OF THERAPEUTIC RANGE DOSES OF PROTHROMBIN COMPLEX CONCENTRATE (PCC) TO PLASMA SAMPLES WITH INR 5
Joseph J. - COMBINING 4T'S PRE-TEST CLINICAL SCORE AND ID-PAGIA HEPARIN/PF4 TEST TO EXCLUDE HEPARIN INDUCED THROMBOCYTOPENIA (HIT)
  - A NOVEL 'FIBRINOGEN-SPIKED' INR METHOD TO MONITOR WARFARIN IN A PATIENT WITH HYPO/DYSFIBRINOGENAEMIA (FIBRINOGEN DARLINGHURST)
Joshi A. - ECONOMIC BENEFITS OF KNEE SURGERY WITH RECOMBINANT ACTIVATED FACTOR VII IN HEMOPHILIA PATIENTS WITH INHIBITORS
  - RECOMBINANT ACTIVATED FACTOR VII VS. ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE AS ON-DEMAND TREATMENT OF JOINT BLEEDS IN HEMOPHILIACS WITH INHIBITORS: A SYSTEMATIC LITERATURE REVIEW
Jouppila A. - PLATELET INTEGRIN ALPHA2BETA1 INTERACTION WITH TYPE I COLLAGEN IS INHIBITED BY A NOVEL SYNTHETIC MOLECULE BTT-3016
Jourdain M. - ANTITHROMBIN REDUCES COAGULATION AND INFLAMMATION IN A PIG MODEL OF ISLET TRANSPLANTATION
Jourde-Chiche N. - THE UREMIC SOLUTE INDOXYL SULFATE INDUCES OXIDATIVE STRESS IN ENDOTHELIAL CELLS
Joutsi-Korhonen L. - SIGNIFICANT DISTINCTION BETWEEN PLASMA- AND PLATELET-DEPENDENT COAGULATION ACTIVITY IN HEMOPHILIA A PATIENTS
Jouvenot Y. - REMOVAL OF PORCINE PARVOVIRUS SPIKED INTO SAMPLES OF HUMAN RECOMBINANT FACTOR VIII
Jovanoska V.V. - THROMBOSIS V.SUBCLAVIAE AND THORACIC OUTLET SYNDROME PAGET-VON SCHROTTER SYNDROME
  - IS THERE A CONNECTION BETWEEN THORACIC OUTLET SYNDROME AND THROMBOSIS OF SIGMOID SINUS?
Jovanoski I.I.J. - IS THERE A CONNECTION BETWEEN THORACIC OUTLET SYNDROME AND THROMBOSIS OF SIGMOID SINUS?
  - THROMBOSIS V.SUBCLAVIAE AND THORACIC OUTLET SYNDROME PAGET-VON SCHROTTER SYNDROME
Jowett S. - COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE
Joyal F. - PERSISTENT VENOUS SYMPTOMS AND SIGNS 1 MONTH AFTER A FIRST DIAGNOSIS OF DVT PREDICT DEVELOPMENT OF THE POST-THROMBOTIC SYNDROME (PTS) DURING 2 YEARS FOLLOW-UP
Jozic J. - MAJOR BLEEDING IN ACUTE CORONARY SYNDROME PATIENTS IS ASSOCIATED WITH A MAKED PRO-INFLAMMATORY RESPONSE: RESULTS FROM THE ACUITY INFLAMMATORY BIOMARKER SUB-STUDY
J-TRACE Investigators  - RISK FACTOR PROFILE AND PATTERN OF USE OF MEDICATIONS IN JAPANESE PATIENTS AT A HIGH RISK OF CARDIOVASCULAR DIEASE: RESULTS FROM THE JAPAN THROMBOSIS REGISTRY FOR ATRIAL FIBRILLATION, CORONARY AND CEREBROVASCULAR DISEASE (J-TRACE)
Jubelirer S.J. - THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) FOLLOWING CARDIAC SURGERY: AN EMERGING SYNDROME
  - CORONARY ARTERY BYPASS GRAFTING (CABG) IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA (ITP)
Jude B. - METABOLIC SYNDROME, PAI-1 AND COLLATERAL VESSEL FORMATION IN PATIENTS WITH DOCUMENTED OCCLUDED CORONARY ARTERIES
  - DRUG ELUTING STENTS: RESTENOSIS VERSUS THROMBOSIS ?
  - ROTEM THROMBOELASTOMETRY IN OBSTETRIC: NEAR PATIENT-TEST AS AN EARLY PREDICTOR OF POST-PARTUM HEMORRHAGE (PPH)
Judge H.M. - P2Y12 BLOCKADE BY PRASUGREL ACTIVE METABOLITE YIELDS COMPLETE INHIBITION OF P2Y12-MEDIATED AMPLIFICATION OF PLATELET RESPONSES
Juhan-Vague I. - RISK OF A FIRST VENOUS OR ARTERIAL EVENT IN CARRIERS OF A FAMILIAL THROMBOPHILIC DEFECT
  - OBESITY, METABOLIC SYNDROME, AND VENOUS THROMBOEMBOLISM
  - DISRUPTION OF PAI-1 CIRCADIAN RHYTHM IN OBESE SUBJECTS MAY EXPLAIN A CHANGE IN THE TIME OF ONSET OF MYOCARDIAL INFARCTION
  - PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY
  - FACTOR V LEIDEN MUTATION AND TROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS ARE MILD GENETIC MODIFIERS OF HEMORRHAGIC PHENOTYPE IN HEMOPHILIA
  - CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME
Juhl D. - HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A PROSPECTIVE STUDY ON THE INCIDENCE, PLATELET-ACTIVATING CAPACITY AND CLINICAL SIGNIFICANCE OF ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODIES (ANTI-PF4/H ABS) OF THE IGG, IGM, AND IGA CLASS
Juin F. - SOURCE OF TISSUE FACTOR LEADING TO DISCREPANT PLASMA FVII LEVELS IN EIGHT FVII-DEFICIENT PATIENTS OF AFRICAN ORIGIN
Jukema J.W. - CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS
  - PLATELET RECEPTOR P2Y12 HAPLOTYPES PREDICT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTIONS
  - THE FACTOR VII ACTIVATING PROTEASE (FSAP) POLYMORPHISM (G534E) IS ASSOCIATED WITH A DECREASED RISK FOR RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION
Julia P. - BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA
Julian J. - RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE RELATIVES (FDRS) OF PATIENTS WITH UNPROVOKED VTE WHO DO NOT HAVE FACTOR V LEIDEN (FVL) OR THE G20210A PROTHROMBIN GENE MUTATION (PGM)
  - EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT)
Juliano L. - SYNDECAN-4 CONTRIBUTES TO ENDOTHELIAL TUBULOGENESIS THROUGH INTERACTIONS WITH TWO MOTIFS INSIDE THE PRO-ANGIOGENIC N-TERMINAL DOMAIN OF THROMBOSPONDIN-1
Julien E. - NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO RARE PLATELET ALLOANTIGENS
Jung S.M. - VON WILLEBRAND FACTOR-GLYCOPROTEIN IB AND INTEGRIN ALPHA2BETA1-COLLAGEN INTERACTIONS MAKE COMPLEMENTARY, COLLAGEN-TYPESPECIFIC CONTRIBUTIONS TO ADHESION
Jung J. - EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS
Jungbauer C. - ANGIOTENSIN-CONVERTING ENZYME (ACE) INSERTION/DELETION (I/D) POLYMORPHISM AND SERUM LEVELS OF ACE IN VENOUS THROMBOEMBOLISM (VTE)
Jungbauer L. - P-SELECTIN (P-SEL) GENE HAPLOTYPES MODULATE SOLUBLE (S) P-SEL LEVELS AND INCREASE THE RISK OF VENOUS THROMBOEMBOLISM (VTE)
Jurek M. - INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR
  - PRT060128, A NOVEL, DIRECT-ACTING ORALLY AVAILABLE P2Y12 ANTAGONIST, CONFERS SUPERIOR ANTITHROMBOTIC ACTIVITY OVER CLOPIDOGREL IN A MOUSE THROMBOSIS MODEL
Jurk K. - THROMBOSPONDIN-1 INHIBITS PLATELET AND MONOCYTE ACTIVATION BY HOCL-OXIDISED PROTEINS
Jurs M. - HAEMATE HS IN PATIENTS WITH SEVERE BLEEDING UNDERGOING VALVE REPLACEMENT DUE TO AORTIC STENOSIS (HAVAS-STUDY)
Jussif J. - PHARMACOLOGICAL TARGETING OF PLATELETS BY ORALLY ACTIVE PI3-KINASE B INHIBITOR PROTECTS AGAINST ARTERIAL THROMBOSIS
Just S. - LOCAL THROMBOLYTIC THERAPY FOR ACUTE ILIOFEMORAL DEEP VENOUS THROMBOSIS IS EFFECTIVE AND PRESERVES VENOUS VALVE FUNCTION. A PROSPECTIVE ONE-CENTRE STUDY OF 86 CASES
Justino H. - ANTITHROMBOTIC THERAPY IN INFANTS WITH SVC SYNDROME: ADDITIONAL MODALITIES ARE REQUIRED
| ISTH 2009